Literature DB >> 20138113

Histories of major depression and premenstrual dysphoric disorder: Evidence for phenotypic differences.

Rebecca R Klatzkin1, Monica E Lindgren, Catherine A Forneris, Susan S Girdler.   

Abstract

This study examined unique versus shared stress and pain-related phenotypes associated with premenstrual dysphoric disorder (PMDD) and prior major depressive disorder (MDD). Sympathetic nervous system (SNS) and hypothalamic-pituitary-adrenal (HPA)-axis measures were assessed at rest and during mental stress, as well as sensitivity to cold pressor and tourniquet ischemic pain tasks in four groups of women: (1) non-PMDD with no prior MDD (N=18); (2) non-PMDD with prior MDD (N=9); (3) PMDD with no prior MDD (N=17); (4) PMDD with prior MDD (N=10). PMDD women showed blunted SNS responses to stress compared to non-PMDD women, irrespective of prior MDD; while women with prior MDD showed exaggerated diastolic blood pressure responses to stress versus never depressed women, irrespective of PMDD. However, only in women with histories of MDD did PMDD women have lower cortisol concentrations than non-PMDD women, and only in non-PMDD women was MDD associated with reduced cold pressor pain sensitivity. These results suggest both unique phenotypic differences between women with PMDD and those with a history of MDD, but also indicate that histories of MDD may have special relevance for PMDD. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20138113      PMCID: PMC2877489          DOI: 10.1016/j.biopsycho.2010.01.018

Source DB:  PubMed          Journal:  Biol Psychol        ISSN: 0301-0511            Impact factor:   3.251


  141 in total

1.  Cardiovascular stress reactivity and mood during the menstrual cycle.

Authors:  G Weidner; L Helmig
Journal:  Women Health       Date:  1990

2.  Cardiovascular and sensory responses to forearm ischemia and dynamic hand exercise.

Authors:  W Maixner; R H Gracely; J R Zuniga; C B Humphrey; G R Bloodworth
Journal:  Am J Physiol       Date:  1990-12

3.  Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression.

Authors:  K S Kendler; L M Karkowski; L A Corey; M C Neale
Journal:  Am J Psychiatry       Date:  1998-09       Impact factor: 18.112

4.  Twenty-four-hour ACTH and cortisol pulsatility in depressed women.

Authors:  E A Young; N E Carlson; M B Brown
Journal:  Neuropsychopharmacology       Date:  2001-08       Impact factor: 7.853

5.  Corticotropin-releasing factor test in melancholic patients in depressed state versus recovery: a comparative study.

Authors:  Luis Pintor; Xavier Torres; Victor Navarro; M A Jesús Martinez de Osaba; Silvia Matrai; Cristobal Gastó
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-03-07       Impact factor: 5.067

6.  African Americans show alterations in endogenous pain regulatory mechanisms and reduced pain tolerance to experimental pain procedures.

Authors:  M Beth Mechlin; William Maixner; Kathleen C Light; Jessica M Fisher; Susan S Girdler
Journal:  Psychosom Med       Date:  2005 Nov-Dec       Impact factor: 4.312

7.  The effects of depressive symptoms on cardiovascular and catecholamine responses to the induction of depressive mood.

Authors:  Mark Hamer; Gohichi Tanaka; Hisayoshi Okamura; Akira Tsuda; Andrew Steptoe
Journal:  Biol Psychol       Date:  2006-07-24       Impact factor: 3.251

Review 8.  The association between premenstrual dysphoric disorder and other mood disorders.

Authors:  K A Yonkers
Journal:  J Clin Psychiatry       Date:  1997       Impact factor: 4.384

Review 9.  Women, anxiety and mood: a review of nomenclature, comorbidity and epidemiology.

Authors:  Jeanne Leventhal Alexander; Lorraine Dennerstein; Krista Kotz; Gregg Richardson
Journal:  Expert Rev Neurother       Date:  2007-11       Impact factor: 4.618

10.  Premenstrual Dysphoric Disorder: Recognition and Treatment.

Authors:  Ellen W. Freeman; Steven J. Sondheimer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2003-02
View more
  14 in total

Review 1.  Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?

Authors:  Shannon K Crowley; Susan S Girdler
Journal:  Psychopharmacology (Berl)       Date:  2014-04-23       Impact factor: 4.530

2.  Luteal serum BDNF and HSP70 levels in women with premenstrual dysphoric disorder.

Authors:  E Oral; H Ozcan; T S Kirkan; S Askin; M Gulec; N Aydin
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-03-02       Impact factor: 5.270

3.  Menstrual mood disorders are associated with blunted sympathetic reactivity to stress.

Authors:  Rebecca R Klatzkin; Adomas Bunevicius; Catherine A Forneris; Susan Girdler
Journal:  J Psychosom Res       Date:  2013-11-12       Impact factor: 3.006

4.  Mindfulness-based Stress Reduction as a Promising Intervention for Amelioration of Premenstrual Dysphoric Disorder Symptoms.

Authors:  Karen Bluth; Susan Gaylord; Khanh Nguyen; Adomas Bunevicius; Susan Girdler
Journal:  Mindfulness (N Y)       Date:  2015-04-03

5.  Documenting stress in caregivers of transplantation patients: initial evidence of HPA dysregulation.

Authors:  Margaret F Bevans; Alyson Ross; Leslie Wehrlen; Stephen D Klagholz; Li Yang; Richard Childs; Sharon L Flynn; Alan T Remaley; Michael Krumlauf; Robert N Reger; Gwenyth R Wallen; Robert Shamburek; Karel Pacak
Journal:  Stress       Date:  2016-03-07       Impact factor: 3.493

6.  The interrelation between premenstrual syndrome and major depression: results from a population-based sample.

Authors:  Christine Forrester-Knauss; Elisabeth Zemp Stutz; Carine Weiss; Sibil Tschudin
Journal:  BMC Public Health       Date:  2011-10-12       Impact factor: 3.295

7.  Lack of association of DRD3 and CNR1 polymorphisms with premenstrual dysphoric disorders.

Authors:  Mesut Yıldız; Mehmet Vural; Mehmet Emin Erdal; Özlem İzci Ay; Şenay Görücü Yılmaz; İbrahim Fatih Karababa; Salih Selek
Journal:  Iran J Reprod Med       Date:  2015-04

8.  Is catechol-o-methyltransferase gene polymorphism a risk factor in the development of premenstrual syndrome?

Authors:  Esma Ozturk Deveci; Adnan Incebiyik; Salih Selek; Aysun Camuzcuoglu; Nese Gul Hilali; Hakan Camuzcuoglu; Mehmet Emin Erdal; Mehmet Vural
Journal:  Clin Exp Reprod Med       Date:  2014-06-30

9.  Response to sertraline is associated with reduction in anxiety-potentiated startle in premenstrual dysphoric disorder.

Authors:  Liisa Hantsoo; Christian Grillon; Mary Sammel; Rachel Johnson; Joanna Marks; C Neill Epperson
Journal:  Psychopharmacology (Berl)       Date:  2021-07-22       Impact factor: 4.530

10.  Premenstrual dysphoria and luteal stress in dominant-social-status female macaques.

Authors:  Mingqi Qiao; Qitao Zhao; Sheng Wei; Huiyun Zhang; Haijun Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-28       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.